Rapport Therapeutics, Inc.

RAPP

—

Advanced chart & tools →

Rapport Therapeutics, Inc.RAPP

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-2.86

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$20.00M

Net income

$-111.48M

Net margin

-557.4%

Gross margin

—

Dividends & financials

Rapport Therapeutics, Inc. (RAPP) reported revenue of $20.00M and net income of $-111.48M, or $-2.86 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.